Get the app
US › Healthcare

Neuroone Medical Technologies Corp (NMTC)

US · Healthcare · Medical Devices

$0.96-7.60%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$2.0M
Revenue YoY
+16.3%
Net profit
$-2.0M
EPS
$-0.28
EPS estimate
$-0.22
Net margin
-101.7%

EPS came in at -0.28 against a street estimate of -0.22 — a miss of 27.3%.

Key statistics

Market cap
$10.2M
Forward P/E
0.0
P/B
3.25
Book value
$0.43
EPS (TTM)
$-1.03
52-week high
$6.12
52-week low
$0.96
50-day MA
$1.57
200-day MA
$3.52
Beta
0.76

Analyst view

Analysts rate Neuroone Medical Technologies Corp a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $7.27.

Shareholding

Insiders
25.44%
Institutions
22.45%

Largest institutional holders

FundStake
Bleichroeder LP7.32%
Vanguard Capital Management, LLC3.87%
Bard Associates Inc3.35%
Perkins Capital Management Inc2.69%
Geode Capital Management, LLC1.03%
Sio Capital Management, LLC0.91%
Renaissance Technologies Corp0.78%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.63%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neuroone Medical Technologies Corp — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.